Showing 1861-1870 of 2038 results for "".
- Three Optometry Practices in Southwest Florida Partner With Private Equity Firm US Eyehttps://modernod.com/news/three-optometry-practices-in-southwest-florida-partner-with-private-equity-firm-us-eye/2478699/Three optometry practices in Southwest Florida—Bayside Eye Center, Fort Myers Eye Center and Valentine Eye Care—have partnered with US Eye and Center For Sight. Financial terms of the deal were not disclosed. Center For Sight is a founding member practice of US Eye, a physician-led,
- Eyenovia Announces First Patients Enrolled in Phase 3 Study of MicroLine for Presbyopiahttps://modernod.com/news/eyenovia-announces-first-patients-enrolled-in-phase-3-study-of-microline-for-presbyopia/2478667/Eyenovia announced that the first set of patients has been enrolled in the company’s phase 3 VISION-1 study of MicroLine, its proprietary pilocarpine formulation delivered via its Optejet dispenser, for the
- Registration Open for International Sports Vision Association 2021 Virtual Annual Conferencehttps://modernod.com/news/registration-open-for-international-sports-vision-association-2021-virtual-annual-conference/2478628/Registration is now open for “Joining Forces to Enhance Athletic Performance,” (www.isva2021.com) the 5th Annual International Sports Vision Association (ISVA) conference. The 2021 conference will be live online on February 20-21, 2021.
- Focus Vision Supplements Now Offer Eyelid Products to Soothe Dry Eye and Aid in Postoperative Healinghttps://modernod.com/news/focus-vision-supplements-now-offer-eyelid-products-to-soothe-dry-eye-and-aid-in-postoperative-healing/2478622/Covalent Medical, owner of Focus Vision Supplements, has developed two new products to aid in pre/postoperative care and soothe the symptoms of occasional dry eye and blepharitis. Focus Eyelid Scrub Formula is a preservative-free, deep-cleaning foam eyelid cleanser
- FDA Approves Eyenovia’s IND Application for MicroLine for Presbyopia, Allowing for Phase 3 Trialshttps://modernod.com/news/fda-approves-eyenovias-ind-application-for-microline-for-presbyopia-allowing-for-phase-3-trials/2478620/Eyenovia announced that the FDA has accepted its investigational new drug (IND) application for MicroLine, a proprietary pilocarpine formulation for the improvement in near vision in patients with presbyopia. The company intends to initiate the phase 3 VISION program, beginning with the VISION-1
- TearClear Announces Successful Completion of Pre-IND Meeting With the FDA for a Preservative-Free Multi-Dose Delivery of Latanoprost for the Treatment of Glaucomahttps://modernod.com/news/tearclear-announces-successful-completion-of-pre-ind-meeting-with-the-fda-for-a-preservative-free-multi-dose-delivery-of-latanoprost-for-the-treatment-of-glaucoma/2478608/TearClear announced successful completion of pre-IND (investigational new drug) meeting with the FDA regarding the development plan for the preservative-free multi-dose delivery of a proprietary latanoprost formulation, including the clinical study design for the registration
- UK Government Asks Regulator to Clear “Temporary Supply” of AstraZeneca’s COVID-19 Vaccinehttps://modernod.com/news/uk-government-asks-regulator-to-clear-temporary-supply-of-astrazenecas-covid-19-vaccine/2478594/The UK government on Friday said that it formally asked the Medicines and Healthcare products Regulatory Agency (MHRA) to assess the suitability of AstraZeneca’s COVID-19 vaccine candidate AZD1222 for “temporary supply.” Health and Social Care Secretary Matt Hancock noted that t
- Slit Lamp Breath Shields Proven to Minimize Spread of Droplets That Can Carry Coronavirus During Eye Examshttps://modernod.com/news/slit-lamp-breath-shields-proven-to-minimize-spread-of-droplets-that-can-carry-coronavirus-during-eye-exams/2478567/Eye exams require close physical contact between patients and physicians, which is not an issue, until a pandemic strikes. Last spring, ophthalmologists began improvising with various forms and sizes of plastic sheeting attached to exam equipment to help protect both the patient and them from the
- Wize Pharma Announces Positive Topline Results in Phase 4 Study of LO2A for Dry Eye in Patients with Sjögren’s Syndromehttps://modernod.com/news/wize-pharma-announces-positive-topline-results-in-phase-4-study-of-lo2a-for-dry-eye-in-patients-with-sjogrens-syndrome/2478529/Wize Pharma reported topline results from its phase 4 clinical trial of its in-license eye drop formula, LO2A, for the symptomatic treatment of dry eye syndrome (DES) in patients with Sjögren’s syndrome. The randomized, double-masked comparative study evaluated LO2A versus Alcon̵
- Regenxbio Announces Presentations at the American Academy of Ophthalmology 2020 Annual Meetinghttps://modernod.com/news/regenxbio-announces-presentations-at-the-american-academy-of-ophthalmology-2020-annual-meeting/2478516/Regenxbio announced that two oral presentations will be presented at the American Academy Ophthalmology (AAO) 2020 Annual Meeting, taking place November 13-15, 2020 in a virtual format. The first presentation will feature data from the RGX-314 phase 1/2 subret